首頁 > 市場調查報告書 > 製藥

感染疾病

補體缺陷檢測市場規模、佔有率和成長分析：按檢測類型、技術、檢體類型、最終用戶和地區分類－產業預測（2026-2033 年）

市場調查報告書

商品編碼

2131160

補體缺陷檢測市場規模、佔有率和成長分析：按檢測類型、技術、檢體類型、最終用戶和地區分類－產業預測（2026-2033 年）

Complement Deficiency Tests Market Size, Share, and Growth Analysis, By Test Type (Complement Protein Quantification Tests, Complement Functional Assays), By Technology, By Sample Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年08月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球補體缺陷檢測市場價值為 2.63 億美元，預計到 2033 年將從 2025 年的 2.8904 億美元成長至 6.1509 億美元，預測期（2026-2033 年）複合年成長率為 9.9%。

全球補體缺陷檢測市場涵蓋旨在識別補體級聯反應（先天免疫的關鍵組成部分）缺陷的診斷檢測。這些檢測對於全身性紅斑性狼瘡和復發性細菌感染疾病等疾病的治療至關重要，識別異常情況有助於改善治療效果。自體免疫和發炎性疾病（尤其是在老年族群中）的日益普遍，以及人們對這些疾病認知的提高和檢測技術的進步，正在推動市場成長。技術創新正在提升檢測能力並加速臨床應用。將這些檢測整合到個人化醫療中是關鍵的成長要素，因為先進的功能和基因檢測對於準確選擇治療對象至關重要。此外，醫保政策的改進和檢查室基礎設施的投資也為市場的持續擴張和創新提供了機會。

全球補體缺陷檢測市場的成長要素

公眾和醫療專業人員對補體系統失衡對健康影響的認知不斷提高，推動了積極篩檢工作的發展。這項轉變促使醫療機構將補體缺陷檢測納入標準篩檢，從而擴大了患者群體，並增加了各醫療機構的需求。此外，預防醫學的日益普及也促使保險公司探索承保方案，降低了檢測普及的門檻，刺激了市場成長。因此，檢測實驗室正在增加對員工培訓和設施改進的投入，以確保提供高品質的服務，從而提高臨床醫生的信任度和患者接受檢測的意願。

限制全球補體缺陷檢測市場的因素

全球補體缺陷檢測市場面臨許多限制因素，主要原因是精準分析所需的高階試劑和設備需要大量資金投入。這導致檢測成本高昂，阻礙了醫療機構的採用，尤其是在預算緊張的情況下。因此，許多醫療機構選擇成本較低的篩檢檢測，限制了詳細缺陷檢測的廣泛應用，儘管其臨床意義重大，但也阻礙了市場擴張。此外，保險報銷政策往往未能跟上技術進步的步伐，導致保險覆蓋範圍不一致，加劇了經濟壓力，迫使臨床醫生選擇更經濟的診斷方案，最終限制了市場成長。

全球補體缺陷檢測市場趨勢

全球補體缺陷檢測市場正呈現出將精準基因體學與傳統診斷方法結合的顯著趨勢。醫療機構正轉向基因譜分析，以提高檢測與補體缺陷相關的潛在易感性的準確性。這將提升診斷準確率，並支持個人化治療方案。基因組學與免疫學的協同作用使臨床醫生能夠將特定基因突變與補體功能障礙聯繫起來，從而為標靶干預和改善患者預後鋪平道路。因此，檢測實驗室正在投資開發整合基因和功能檢測的先進多重檢測平台，在精準醫療日益普及的推動下，該市場正處於持續成長的軌道上。

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

F. Hoffmann-La Roche AG
Siemens Healthineers AG
Abbott Laboratories
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
QIAGEN NV
DiaSorin SpA
Trinity BIoTech plc
Werfen, SA
Buhlmann Laboratories AG
Binding Site Group Limited
The Sebia Group
Euroimmun Medizinische Labordiagnostika AG
QuidelOrtho Corporation
Agilent Technologies, Inc.
Bio-Techne Corporation
Diasource ImmunoAssays SA
GenScript BIoTech Corporation
Abcam plc

結論與建議

簡介目錄

Product Code: SQMIG35J2750

Global Complement Deficiency Tests Market size was valued at USD 263.0 Million in 2024 and is poised to grow from USD 289.04 Million in 2025 to USD 615.09 Million by 2033, growing at a CAGR of 9.9% during the forecast period (2026-2033).

The global market for complement deficiency tests includes diagnostic assays designed to identify deficiencies in the complement cascade, a crucial part of innate immunity. These tests are vital in managing conditions like systemic lupus erythematosus and recurrent bacterial infections, where identifying abnormalities facilitates better treatment outcomes. The growing prevalence of autoimmune and inflammatory disorders, particularly among aging populations, drives market growth, supported by increased awareness and advancements in assay technology. Innovations have enhanced detection capabilities, encouraging adoption in clinical settings. The incorporation of these tests into personalized medicine is a key growth factor, as precise patient selection for therapies necessitates advanced functional assays and genetic testing. Additionally, evolving reimbursement policies and investments in laboratory infrastructure present opportunities for sustained expansion and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Complement Deficiency Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Complement Deficiency Tests Market Segments Analysis

Global complement deficiency tests market is segmented by test type, technology, sample type, end user and region. Based on test type, the market is segmented into complement protein quantification tests, complement functional assays, complement component deficiency tests and genetic complement deficiency tests. Based on technology, the market is segmented into immunoassays, molecular diagnostics and functional assays. Based on sample type, the market is segmented into blood/serum and plasma. Based on end user, the market is segmented into hospitals, diagnostic laboratories and academic & research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Complement Deficiency Tests Market

Increasing awareness among the public and healthcare professionals regarding the health implications of abnormalities in the complement system is driving a proactive approach to screening. This shift prompts healthcare providers to integrate complement deficiency tests into standard evaluations, thereby broadening the patient demographic for these diagnostics and raising demand across various care environments. Additionally, the growing emphasis on preventive health care encourages insurance providers to explore coverage options, which lowers barriers to test implementation and promotes market growth. As a result, laboratories are investing in staff training and facility improvements, ensuring quality service delivery that enhances clinician trust and patient willingness to undergo testing.

Restraints in the Global Complement Deficiency Tests Market

The Global Complement Deficiency Tests market faces significant restraints primarily due to the advanced reagents and instrumentation needed for precise analysis, which requires substantial capital investment. This results in higher test costs that can deter healthcare providers, particularly in budget-conscious settings. As a consequence, many institutions often opt for cheaper screening alternatives, which limits the uptake of thorough deficiency assays and hinders market expansion despite their clinical importance. Additionally, reimbursement policies often do not keep pace with technological advancements, leading to inconsistent coverage that intensifies financial concerns and pushes clinicians toward more economical diagnostic options, ultimately restricting market growth.

Market Trends of the Global Complement Deficiency Tests Market

The Global Complement Deficiency Tests market is witnessing a significant trend towards the integration of precision genomics into traditional diagnostic practices. Healthcare providers are moving towards genetic profiling to improve the detection of underlying predispositions related to complement deficiencies, which enhances diagnostic precision and supports personalized treatment approaches. This synergy between genomics and immunology allows clinicians to link specific gene variants to complement functional abnormalities, which paves the way for targeted interventions and better patient outcomes. Consequently, laboratories are investing in advanced multiplex platforms that amalgamate genetic and functional testing, positioning the market for continued growth fueled by the increasing adoption of precision medicine.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Complement Deficiency Tests Market Size by Test Type & CAGR (2026-2033)

Market Overview
Complement Protein Quantification Tests
Complement Functional Assays
Complement Component Deficiency Tests
Genetic Complement Deficiency Tests

Global Complement Deficiency Tests Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunoassays
Molecular Diagnostics
Functional Assays

Global Complement Deficiency Tests Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood/Serum
Plasma

Global Complement Deficiency Tests Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Academic & Research Institutes

Global Complement Deficiency Tests Market Size & CAGR (2026-2033)

North America (Test Type, Technology, Sample Type, End User)
- US
- Canada
Europe (Test Type, Technology, Sample Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Technology, Sample Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Technology, Sample Type, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Technology, Sample Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werfen, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Buhlmann Laboratories AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Binding Site Group Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Sebia Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Euroimmun Medizinische Labordiagnostika AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diasource ImmunoAssays SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments